SCHEMBL5072033

SCHEMBL5072033

[O]C(Oc1cccc2ccccc12)c1ccccc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A2 P23975 10/20 0.53
SLC6A4 P31645 10/20 0.53
SLC6A3 Q01959 1/20 0.51
KDM4E B2RXH2 3/20 0.47
ALDH1A1 P00352 3/20 0.47
HPGD P15428 1/20 0.47
TDP1 Q9NUW8 1/20 0.47
KMT2A Q03164 3/20 0.45
HSD17B10 Q99714 2/20 0.45
MEN1 O00255 2/20 0.45
CYP1A2 P05177 1/20 0.45
CYP2C19 P33261 1/20 0.45
KCNA3 P22001 1/20 0.43
PGR P06401 1/20 0.42
GAA P10253 1/20 0.42
PTGS1 P23219 1/20 0.42
MAPK1 P28482 1/20 0.42
HTR1B P28222 1/20 0.42
RAB9A P51151 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3276460 0.83 ALDH1A1 (0.52) SLC6A2SLC6A4SLC6A3KDM4EALDH1A1
SCHEMBL28031218 0.82 SLC6A2 (0.54) SLC6A2SLC6A4SLC6A3KDM4EALDH1A1
SCHEMBL28827105 0.79 KDM4E (0.51) SLC6A2SLC6A4SLC6A3KDM4EALDH1A1
SCHEMBL1356983 0.78 HTR1B (0.47) SLC6A2SLC6A4KDM4EALDH1A1HPGD
SCHEMBL8009191 0.78 CYP1A2 (0.49) SLC6A2SLC6A4SLC6A3KDM4EALDH1A1
SCHEMBL11577421 0.77 KDM4E (0.52) SLC6A2SLC6A4SLC6A3KDM4EALDH1A1
SCHEMBL28840585 0.77 KDM4E (0.51) SLC6A2SLC6A4KDM4EALDH1A1HPGD
SCHEMBL27852222 0.76 SLC6A2 (0.49) SLC6A2SLC6A4SLC6A3KDM4EALDH1A1
SCHEMBL9345655 0.76 ALDH1A1 (0.54) SLC6A2SLC6A4SLC6A3KDM4EALDH1A1
SCHEMBL6565995 0.76 ALDH1A1 (0.54) SLC6A2SLC6A4KDM4EALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2545923-A1 Antibacterial agents Alchemia Limited (AU) 2013-01-16 EP disclosed
EP-1934388-B1 METHOD OF DRUG DESIGN ALCHEMIA LTD (AU) 2012-12-05 EP disclosed
EP-1934388-A1 METHOD OF DRUG DESIGN Alchemia Ltd (AU) 2008-06-25 EP disclosed
EP-1797428-A1 SELECTIVE INHIBITORS Alchemia Pty Ltd (AU) 2007-06-20 EP disclosed
WO-2007038829-A1 METHOD OF DRUG DESIGN ALCHEMIA LTD (AU) 2007-04-12 WO disclosed
WO-2006037159-A1 SELECTIVE INHIBITORS ALCHEMIA LIMITED (AU) 2006-04-13 WO disclosed